Transcript Curriculum Map - NAPLEX Competencies

Xavier University of Louisiana
College of Pharmacy
Curriculum Map – NAPLEX Competencies
Primary Analysis
Completed by ADPA
1
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the presence
of a disease or medical condition, assess the need for treatment and/or referral, and
identify patient-specific factors that effect health, pharmacotherapy, and/or disease
management
1.1.1 – Identify and assess patient information including medication, laboratory and
disease state histories.
CBCO
Should this competency be introduced in the first year?
Teaching Methods
Active learning – 4/6 courses; occurs in the 3rd and 4th year
Lecture – 3/6 courses
Other – need to define-3 courses
Assessment
Methods
Performance based – 4/6 courses; occurs in the 3rd and 4th
year
Test/quiz – 4/6 courses
Other-need to define-1 course
2
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the
presence of a disease or medical condition, assess the need for treatment
and/or referral, and identify patient-specific factors that effect health,
pharmacotherapy, and/or disease management
1.1.2 – Identify and/or use instruments and techniques related to patient
assessment and diagnosis.
CBCO
Should this competency be introduced in the first year?
Teaching Methods Active Learning – 5/7 courses; occurs in the 2nd – 4th
year
Lecture – 4/7 courses
Other-need to define-2 courses
Assessment
Methods
Performance based – 4/7 courses; occurs in the 3rd and
4th year
Test/quiz – 4/7 courses
3
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the
presence of a disease or medical condition, assess the need for treatment
and/or referral, and identify patient-specific factors that effect health,
pharmacotherapy, and/or disease management
1.1.3 – Identify and define the terminology, signs and symptoms
associated with diseases and medical conditions.
CBCO
Reinforced in the fourth year
Teaching Methods Active Learning – 4/9 courses; occurs in the 2nd – 4th
year
Lecture – 7/9 courses
Other-need to define – 3 courses
Assessment
Methhods
Performance based – 3/9 courses; occurs in the 3rd
and 4th year
Test/quiz – 7/9 courses
Other-need to define – 1 course
4
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.1.0 – Obtain, interpret and evaluate patient information to determine the
presence of a disease or medical condition, assess the need for treatment
and/or referral, and identify patient-specific factors that effect health,
pharmacotherapy, and/or disease management
1.1.4 – Identify and evaluate patient factors, genetic factors, biosocial
factors, and concurrent drug therapy that are relevant to the maintenance
of wellness and the prevention or treatment of a disease or medical
condition.
CBCO
Introduced and Reinforced in the 4th year
Teaching Methods Active learning – 4/8 courses; occurs in the 3rd and 4th
year
Lecture – 5/8 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-4/8; occurs in the 3rd and 4th year
Test/quiz- 6/8 courses
Other-need to define-2 courses
5
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and
delivery systems.
1.2.1 – Identify specific uses and indications for drug products.
CBCO
Reinforced in the 4th year
Teaching Methods Active learning – 4/11 courses; occurs in the 3rd and 4th
year
Lecture – 7/11 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-4/11 courses; occurs in the 3rd and
4th year
Test/quiz-9/11 courses
6
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and
delivery systems.
1.2.2 – Identify the known or postulated sites and mechanisms of action of
pharmacotherapeutic agents.
CBCO
Reinforced in the fourth year
Teaching Methods Active learning-4/10 courses; occurs in the 3rd and 4th
year
Lecture-7/10 courses
Other-need to define-3 courses
Assessment
Methods
Performance based-5/10 courses; occurs in the 2nd-4th
year
Test/quiz-9/10 courses
7
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and
delivery systems.
1.2.3 –Evaluate drug therapy for the presence of pharmacotherapeutic
duplications and interactions with other drugs, food, diagnostic tests, and
monitoring procedures.
CBCO
Introduced in the 3rd year; reinforced in the 4th year
Teaching methods Active learning-5/7 courses; occurs in the 2nd-4th year
Lecture-3/7 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-4/7 courses; occurs in the 3rd and
4th year
Test/quiz-4/7 courses
8
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and delivery
systems.
1.2.4 –Identify contraindications, warnings, and precautions associated with a
drug product’s active and inactive ingredients.
CBCO
Reinforced in the 4th year
Teaching Methods Active learning-5/9 courses; occurs in the 2nd - 4th year
Lecture-6/9 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-5/9 courses; occurs in the 3rd and 4th
year
Test/quiz-8/9
9
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and
delivery systems.
1.2.5 –Identify physiochemical properties of drug substances that affect their
solubility, pharmacodynamic and pharmacokinetic properties, pharmacologic
actions and stability.
CBCO
Reinforced in the 4th year
Teaching Methods Active learning-4/12; occurs in the 3rd and 4th year
Lecture-8/12 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-7/12 courses; occurs in each year
Test/quiz-8/12 courses
10
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and
delivery systems.
1.2.6 – Interpret and apply pharmacodynamic and pharmacokinetic
principles to calculate and determine appropriate drug dosing regimens.
CBCO
Reinforced in the 4th year
Teaching Methods Active learning-4/9 courses; occurs in the 3rd and 4th
year
Lecture-7/9 courses
Other-need to define;2 courses
Assessment
Methods
Performance based-6/9 courses; occurs in each year
Test/quiz-7/9 courses
11
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.2.0 – Identify, evaluate, and communicate to the patient or health-care
provider, the appropriateness of the patient’s specific pharmacotherapeutic
agents, dosing regimens, dosage forms, routes of administration, and
delivery systems.
1.2.7 – Interpret and apply biopharmaceutic principles and the
pharmaceutical characteristics of drug dosage forms and delivery systems, to
assure bioavailability and enhance patient compliance.
CBCO
Reinforced in the 4th year
Teaching Methods Active learning-4/9 courses; occurs in the 3rd and 4th
year
Lecture-5/9 courses
Other-need to define-1 course
Assessment
Methods
Performance based-5/9 courses; occurs in the 2nd-4th
year
Test/quiz-6/9 courses
12
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care professionals,
and providing patient education.
1.3.1 – Identify pharmacotherapeutic outcomes and endpoints.
CBCO
Introduced in the 3rd year; Reinforced in the 4th
year
Teaching Methods Active learning-4/7 courses; occurs in the 3rd and 4th
year
Lecture-4/7 courses
Other-need to define-1 course
Assessment
Methods
Performance based-4/7 courses; occurs in the 3rd and
4th year
Test/quiz-5/7 courses
13
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the
patient and/or patient information, collaborating with other health care
professionals, and providing patient education.
1.3.2 – Evaluate patient signs and symptoms, and the results of
monitoring tests and procedures to determine the safety and
effectiveness of pharmacotherapy.
CBCO
Introduced in the 3rd year; Reinforced in the 4th
year
Teaching Methods Active learning-4/5 courses; occurs in the 2nd-4th
year
Lecture-3/5 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-3/5 courses; occurs in the 3rd
and 4th year
Test/quiz-4/5 courses
14
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care
professionals, and providing patient education.
1.3.3 – Identify, describe the mechanism of, and remedy adverse reactions,
allergies, side effects and iatrogenic or drug-induced illness.
CBCO
Introduced in the 3rd year; reinforced in the 4th
year
Teaching Methods Active learning-4/8 courses; occurs in the 3rd and 4th
year
Lecture-5/8 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-4/8 courses; occurs in the 3rd and
4th year
Test/quiz-4/8 courses
15
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care professionals,
and providing patient education.
1.3.4 – Prevent, recognize, and remedy medication non-adherence, misuse
or abuse.
CBCO
Introduced in the 3rd year; reinforced in the 4th
year
Teaching Methods Active learning-4/6 courses; occurs in the 3rd and 4th
year
Lecture-3/6 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-4/6 courses; occurs in the 3rd and
4th year
Test/quiz-2/6 courses
16
Area 1 - Assure Safe and Effective Pharmacotherapy and
Optimize Therapeutic Outcomes
1.3.0 –Manage the drug regimen by monitoring and assessing the patient
and/or patient information, collaborating with other health care
professionals, and providing patient education.
1.3.5 – Recommend pharmacotherapeutic alternatives.
CBCO
Introduced in the 3rd year; reinforced in the 4th
year
Teaching Methods Active learning-4/7 courses; occurs in the 2nd-4th year
Lecture-5/7 courses
Other-need to define- 2 courses
Assessment
Methods
Performance based-3/7 courses; occurs in the 3rd and
the 4th year
Test/quiz-6/7 courses
17
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 – Perform calculations required to compound, dispense, and
administer medication.
2.1.1 – Calculate the quantity of medication to be compounded or
dispensed; reduced and enlarge formulation quantities and calculate the
quantity of ingredients needed to compound the proper amount of the
preparation.
CBCO
Introduced in the 3rd year; reinforced in the 1st
year; this competency is covered in only 3 courses
Teaching Methods Active learning-1/3 courses; occurs in the 3rd year
Lecture-2/3 courses
Assessment
Methods
Performance based-2/3 courses; occurs in the 2nd and
3rd year
Test/quiz-1/3 courses
18
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 – Perform calculations required to compound, dispense, and
administer medication.
2.1.2 – Calculate nutritional needs and the caloric content of nutrient
sources.
Comments
This competency is only covered in one course
19
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 – Perform calculations required to compound, dispense, and administer
medication.
2.1.3 – Calculate the rate of drug administration.
CBCO
Appears to be okay.
Teaching Methods Active learning-1/4 courses; occurs in the 3rd year
Lecture-3/4 courses
Assessment
Methhods
Performance based-1/4 courses; occurs in the 3rd year
Test/quiz-3/4 courses
20
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.1.0 – Perform calculations required to compound, dispense, and
administer medication.
2.1.4 – Calculate or convert drug concentrations, ratio strengths, and/or
extent of ionization.
CBCO
Appears to be okay.
Teaching Methods Active learning-1/4 courses; occurs in the 3rd year
Lecture-4/4 courses
Assessment
Methods
Performance based-2/4 courses; occurs in the 2nd
and 3rd year
Test/quiz-3/4 courses
21
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe
and effective use.
2.2.1 – Identify drug products by their generic, brand, and/or common
names.
CBCO
Reinforced in the fourth year
Teaching Methods Active learning-2/9 courses; occurs in the 3rd and 4th
year
Lecture-5/9 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-2/9 courses; occurs in the 3rd and
4th year
Test/quiz – 8/9 courses
22
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe
and effective use.
2.2.2 – Determine whether a particular drug dosage strength or dosage
form is commercially available, and whether it is available on a
nonprescription basis.
CBCO
Introduced in the 4th year
Teaching Methods Active learning-2/7 courses; occurs in the 3rd and 4th
year
Lecture-4/7 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-2/7 courses; occurs in the 3rd
and 4th year
Test/quiz-3/7 courses
Other-need to define-1 course
23
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe
and effective use.
2.2.3 – Identify commercially available drug products by their characteristic
physical attributes.
CBCO
This competency is only covered in 1 course.
24
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe
and effective use.
2.2.4– Interpret and apply pharmacokinetic parameters and quality
assurance data to determine equivalence among manufactured drug
products, and identify products for which documented evidence of
inequivalence exists.
CBCO
Appears to be okay
Teaching Methods Active learning-1/4 courses; occurs in the 3rd year
Lecture-2/4 courses
Other-need to define-1 course
Assessment
Methods
Performance based – 0/4 courses
Test/quiz-2/4 courses
Other-need to define-1 course
25
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe
and effective use.
2.2.5 – Identify and communicate appropriate information regarding
packaging, storage, handling, administration, and disposal of
medications.
CBCO
Introduced in the 3rd and 4th year
Teaching Methods Active learning-2/7 courses; occurs in the 3rd and 4th
year
Lecture-4/7 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-1/7 courses; occurs in the 4th
year
Test/quiz-4/7 courses
Other-need to define-1 course
26
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.2.0 – Select and dispense medications in a manner that promotes safe
and effective use.
2.2.6 – Identify and describe the use of equipment and apparatus
required to administer medications.
CBCO
Introduced in the 3rd year; this competency is
not reinforced
Teaching Methods Active learning – 3/6 courses; occurs in the 3rd and
4th year
Lecture-3/6 courses
Other-need to define-1 course
Assessment
Methods
Performance based-1/6 courses; occurs in the 3rd
year
Test/quiz-2/6 courses
Other-need to define-3 courses
27
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.3.0 – Prepare and compound extemporaneous preparations and
sterile products.
2.3.1 – Identify and describe techniques and procedures related to
drug preparation, compounding and quality assurance.
CBCO
Introduced in the 3rd year
Teaching Methods Active learning-1/4 courses; occurs in the 3rd year
Lecture-3/4 courses
Assessment
Methods
Performance based-1/4 courses; occurs in the 2nd
year
Test/quiz-3/4 courses
28
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.3.0 – Prepare and compound extemporaneous preparations and sterile
products.
2.3.2 – Identify and use equipment necessary to prepare and
extemporaneously compound medications.
CBCO
Introduced in the 3rd year; this competency is
not reinforced
Teaching Methods
Active learning-1/3 courses; occurs in the 3rd year
Lecture-2/3 courses
Assessment Methods
Performance based-1/3 courses; occurs in the 2nd
year
Test/quiz-2/3 courses
29
Area 2 - Assure Safe and Accurate Preparation
and Dispensing of Medications
2.3.0 – Prepare and compound extemporaneous preparations and sterile
products.
2.3.3 – Identify the important physiochemical properties of a preparation’s
active and inactive ingredients; describe the mechanism of, and the
characteristic evidence of incompatibility or degradation; and identify
methods for achieving stabilization of the preparation
CBCO
Introduced in the 3rd year; this competency is
not emphasized
Teaching methods Active learning-1/7 courses; occurs in the 3rd year
Lecture-6/7 courses
Assessment
Methods
Performance based-2/7 courses; occurs in the 2nd
year
Test/quiz-5/7 courses
30
Area 3 - Provide Health Care Information and
Promote Public Health
3.1.0 – Access, evaluate, and apply information to promote optimal health
care.
3.1.1 – Identify the typical content and organization of specific sources of
drug and health information for both health care providers and consumers.
CBCO
Introduced and reinforced in the 4th year;
introduced in the 3rd year
Teaching Methods Active learning-3/3 courses; occurs in the 1st, 3rd, and 4th
year
Lecture-1/3 courses
Other-need to define-2 courses
Assessment
Methods
Performance based-3/3 courses; occurs in the 1st, 3rd,
and 4th year
Test/quiz-0/3 courses
Other-need to define-1 course
31
Area 3 - Provide Health Care Information and
Promote Public Health
3.1.0 – Access, evaluate, and apply information to promote optimal health care.
3.1.2 – Evaluate the suitability, accuracy, and reliability of information from
reference sources by explaining and evaluating the adequacy of experimental
design and by applying and evaluating statistical test and parameters.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
PSL – I
I
O, SGD, L
IGP, HW, OP, P,
RP
Biopharmaceutics
R
L
T
IPPE – III
I
SGD
RP, OP, IGP
Clinical Rotation
R, E
O, CS, SGD
O, OP
32
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 – Educate the public and health care professionals regarding medical
conditions, wellness, dietary supplements, and medical devices.
3.2.1 – Provide health care information regarding the prevention and treatment
of diseases and medical conditions, including emergency patient care.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy Law
R
L
T
IPPE – III
I
SGD
IGP
Clinical Rotation
R, E
O, SGD
D, HW, OP
33
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 – Educate the public and health care professionals regarding medical
conditions, wellness, dietary supplements, and medical devices.
3.2.2 – Provide health care information regarding nutrition, lifestyle, and other
non-drug measures that are effective in promoting health or preventing or
minimizing the progression of a disease or medical condition.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Biochemistry
I
L
T
Pharmacy
Practice
R
CS
OP, IGP
Pharmacy Law
R
L
T
IPPE – III
I
SGD
?
Clinical Rotation
R, E
SGD, O
OP, D
34
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 – Educate the public and health care professionals regarding medical
conditions, wellness, dietary supplements, and medical devices.
3.2.3 – Provide information regarding the documented uses, adverse effects
and toxicities of dietary supplements.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy
Practice
E
CS
RP, OP, IGP
Pharmacy Law
R
L
T
IPPE – III
I
SGD
?
Clinical Rotation
R, E
SGD, CS, O
OP, IGP, D
35
Area 3 - Provide Health Care Information and
Promote Public Health
3.2.0 – Educate the public and health care professionals regarding medical
conditions, wellness, dietary supplements, and medical devices.
3.2.4 – Provide information regarding the selection, use and care of
medical/surgical appliances and devices, self-care products, and durable
medical equipment, as well as products and techniques for self-monitoring of
health status and medical conditions.
Course
CBCO
Teaching
method(s)
Assessment
method(s)
Pharmacy Law
R
L
T
Clinical Rotation
R, E
SGD, O
OP, D
36